At the news
? NEUTRALIMPACT 2/10 144 filed Oct 30, 2026 at 16:14 ET
Marion McCourt, an officer of Regeneron Pharmaceuticals, filed a Form 144 notice of intent to sell 1,132 shares of common stock, valued at approximately $984,195 based on the filing date price. The shares were acquired via restricted stock award vesting in December 2023. This is a routine insider sale notice representing a small fraction of the company's $83.7B market cap.
- Marion McCourt, an officer of Regeneron, filed Form 144 to sell 1,132 shares of common stock.
- Estimated sale value is approximately $984,195 based on the filing date price of ~$869 per share.
- Shares were acquired on 12/12/2023 via restricted stock award vesting from the issuer.
- The sale is proposed to occur on or after 10/30/2026 on Nasdaq.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access